Latest Geographic Expansion News

De.mem Limited has acquired Core Chemicals Ltd for approximately $3 million, significantly expanding its footprint in the Australian gold mining sector and enhancing its pro-forma EBITDA to $1.6 million.

Alcidion Group Limited has reported a record FY25 with strong revenue growth, major NHS contract wins, and expanded AI capabilities in its Miya Precision platform, setting the stage for global healthcare IT expansion.

Telix Pharmaceuticals reports a robust 53% revenue jump in Q3 2025 and raises its full-year guidance, underpinned by key reimbursement wins and expanding clinical programs.

Resonance Health reveals a robust growth strategy targeting $17 million revenue by FY26, powered by AI-enhanced medical imaging and global clinical trial services expansion.

Carnegie Clean Energy has addressed a sharp rise in its share price and trading volume, attributing the movement to growing interest from US investors amid its wave energy ventures.

Spacetalk Ltd has raised $4.05 million through a combination of a conditional placement and convertible notes to accelerate its geographic expansion and app development, alongside appointing a seasoned director to its board.

Atturra Limited has completed the acquisition of Blue Connections Pty Ltd for $18 million upfront, aiming to boost its managed services capabilities and establish a key Victorian hub. The deal includes performance-based earn-outs, signaling strategic growth in IT solutions.

FirstWave Cloud Technology reports a significant reduction in losses for FY25, driven by operational restructuring and new AI initiatives, while setting sights on Latin American expansion.

ClearVue Technologies reported a striking 553% revenue increase to nearly $250,000 in FY2025, alongside a 7% reduction in net loss, driven by strategic partnerships and global project wins.

Unith Ltd reported a 19% revenue increase to $5.37 million for FY25, driven by its new Digital Human platform launch and B2C expansion, yet net losses widened significantly to $4.95 million. The company’s strategic partnerships and capital raise underpin its growth ambitions amid ongoing cash burn.

Firebrick Pharma reported a substantial increase in Nasodine Nasal Spray revenues in FY25, alongside a widening net loss driven by reduced R&D incentives and increased marketing investments. The company is advancing its international rollout with new licensing deals and board appointments.

Waterco Limited reported a modest 4% revenue increase for FY25 but saw net profit fall sharply by 31%, weighed down by restructuring and foreign exchange losses. The company maintains its dividend and eyes growth through innovation and regional expansion.